Arjunolic acid: beneficial role in type 1 diabetes and its associated organ pathophysiology (Q38001051)

26 August 2017

title

Arjunolic acid: beneficial role in type 1 diabetes and its associated organ pathophysiology (English)

1 reference

26 August 2017

0 references

1 reference

ChEBI release 2020-05-28

1 reference

Prasenjit Manna

1 reference

26 August 2017

Parames C Sil

series ordinal

1 reference

26 August 2017

publication date

3 May 2012

1 reference

26 August 2017

published in

Free Radical Research

1 reference

26 August 2017

1 reference

26 August 2017

1 reference

26 August 2017

page(s)

815-830

1 reference

Diabetes, oxidative stress, and antioxidants: a review

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Radicals and oxidative stress in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

The pathobiology of diabetic complications: a unifying mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Diabetes and antioxidants: myth or reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Glucose and reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Nitric oxide regulates the polyol pathway of glucose metabolism in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Vascular function, insulin resistance and fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Increasing plasma fatty acids elevates F2-isoprostanes in humans: implications for the cardiovascular risk factor cluster.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Oxidative stress parameters in type I, type II and insulin-treated type 2 diabetes mellitus; insulin treatment efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Oxidative Stress and Diabetic Complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Immune dysfunction in patients with diabetes mellitus (DM).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Cytokine release by murine spleen cells following multiple low dose streptozotocin-induced diabetes and treatment with a TNFα transcriptional inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Relationship between hyperglycemia and infection in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Impaired immune responses in streptozotocin-induced type I diabetes in mice. Involvement of high glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Mitochondrial nutrients improve immune dysfunction in the type 2 diabetic Goto-Kakizaki rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Aldose reductase expression is induced by hyperglycemia in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Oxidative stress and diabetic cardiomyopathy: a brief review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Cardiac oxidative stress is elevated at the onset of dilated cardiomyopathy in streptozotocin-diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Regulation of intracellular Ca2+ in the heart during diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Diabetic cardiomyopathy revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

New Insights on Oxidative Stress and Diabetic Complications May Lead to a “Causal” Antioxidant Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Changes in hepatic glutathione metabolism in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Type 2 Diabetes Mellitus-Induced Hyperglycemia in Patients with NAFLD and Normal LFTs: Relationship to Lipid Profile, Oxidative Stress and Pro-Inflammatory Cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

A review on the role of antioxidants in the management of diabetes and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Review on some plants of Indian traditional medicine with antioxidant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Leads from Indian medicinal plants with hypoglycemic potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Medicinal plants of India with anti-diabetic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Biological activity of two related triterpenes isolated from Combretum nelsonii (Combretaceae) leaves.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Antibacterial triterpenes from Syzygium guineense (Myrtaceae).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Triterpenoids from the flower of Campsis grandiflora K. Schum. as human acyl-CoA: cholesterol acyltransferase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Effect of quercetin on tachykinin-induced plasma extravasation in rat urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Evaluation of phytoconstituents of Terminalia arjuna for wound healing activity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Insect growth inhibitor activity of arjunolic acid isolated from Cornus capitata.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Protection of arsenic-induced hepatic disorder by arjunolic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Arsenic-induced oxidative myocardial injury: protective role of arjunolic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Arjunolic acid attenuates arsenic-induced nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Protective effect of arjunolic acid against arsenic-induced oxidative stress in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Protection of arsenic-induced testicular oxidative stress by arjunolic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Cytoprotective effect of arjunolic acid in response to sodium fluoride mediated oxidative stress and cell death via necrotic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Acetaminophen induced renal injury via oxidative stress and TNF-alpha production: therapeutic potential of arjunolic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

The protective role of arjunolic acid against doxorubicin induced intracellular ROS dependent JNK-p38 and p53-mediated cardiac apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Streptozotocin induced activation of oxidative stress responsive splenic cell signaling pathways: protective role of arjunolic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Protective role of arjunolic acid in response to streptozotocin-induced type-I diabetes via the mitochondrial dependent and independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Bax directly induces release of cytochrome c from isolated mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Apoptosis commitment--translating survival signals into decisions on mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Duration of streptozotocin-induced diabetes differentially affects p38-mitogen-activated protein kinase (MAPK) phosphorylation in renal and vascular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Prophylactic role of arjunolic acid in response to streptozotocin mediated diabetic renal injury: activation of polyol pathway and oxidative stress responsive signaling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Aldose reductase inhibition counteracts nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic rat kidney and high-glucose-exposed human mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Aldose reductase and the role of the polyol pathway in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Oxalate selectively activates p38 mitogen-activated protein kinase and c-Jun N-terminal kinase signal transduction pathways in renal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Mitogen-activated protein kinase p38 mediates reduced nerve conduction velocity in experimental diabetic neuropathy: interactions with aldose reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Altered activities of transcription factors and their related gene expression in cardiac tissues of diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Beneficial effects of selenium on some enzymes of diabetic rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

The NF-kappa B and I kappa B proteins: new discoveries and insights

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Glycaemic control, markers of endothelial cell activation and oxidative stress in children with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Therapeutic potential of angiostatin in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Activation of NADPH oxidase during progression of cardiac hypertrophy to failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Contribution of type 1 diabetes to rat liver dysfunction and cellular damage via activation of NOS, PARP, IkappaBalpha/NF-kappaB, MAPKs, and mitochondria-dependent pathways: Prophylactic role of arjunolic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Mitogen-activated protein kinases as glucose transducers for diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Taurine prevents apoptosis induced by high ambient glucose in human tubule renal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Antioxidants in the Treatment of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Oxidative stress and antioxidant treatment in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

Use of antioxidant nutrients in the prevention and treatment of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.683431

10.3109/10715762.2012.683431

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference